19 employees
BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.
2004
$4M
from 1 investors over 1 rounds
BriaCell Therapeutics Corp raised $4M on May 15, 2023
Investors: Prevail Partners LLC